IBDEI1EJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25136,1,5,0)
 ;;=5^CML,In Relapse
 ;;^UTILITY(U,$J,358.3,25136,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,25137,0)
 ;;=284.81^^145^1535^14
 ;;^UTILITY(U,$J,358.3,25137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25137,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,25137,1,5,0)
 ;;=5^Aplastic Anemia d/t Drugs
 ;;^UTILITY(U,$J,358.3,25137,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,25138,0)
 ;;=284.89^^145^1535^13
 ;;^UTILITY(U,$J,358.3,25138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25138,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,25138,1,5,0)
 ;;=5^Aplastic Anemia d/t Chronic Disease
 ;;^UTILITY(U,$J,358.3,25138,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,25139,0)
 ;;=289.84^^145^1535^119
 ;;^UTILITY(U,$J,358.3,25139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25139,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,25139,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,25139,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,25140,0)
 ;;=V10.91^^145^1535^67
 ;;^UTILITY(U,$J,358.3,25140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25140,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,25140,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,25140,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,25141,0)
 ;;=V10.91^^145^1535^66
 ;;^UTILITY(U,$J,358.3,25141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25141,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,25141,1,5,0)
 ;;=5^H/O Malignant Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,25141,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,25142,0)
 ;;=465.9^^145^1536^70
 ;;^UTILITY(U,$J,358.3,25142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25142,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,25142,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,25142,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,25143,0)
 ;;=462.^^145^1536^61
 ;;^UTILITY(U,$J,358.3,25143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25143,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,25143,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,25143,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,25144,0)
 ;;=466.0^^145^1536^3
 ;;^UTILITY(U,$J,358.3,25144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25144,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,25144,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,25144,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,25145,0)
 ;;=112.1^^145^1536^79
 ;;^UTILITY(U,$J,358.3,25145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25145,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,25145,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,25145,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,25146,0)
 ;;=616.0^^145^1536^13
 ;;^UTILITY(U,$J,358.3,25146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25146,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,25146,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,25146,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,25147,0)
 ;;=599.0^^145^1536^71
 ;;^UTILITY(U,$J,358.3,25147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25147,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,25147,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,25147,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,25148,0)
 ;;=460.^^145^1536^45
 ;;^UTILITY(U,$J,358.3,25148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25148,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,25148,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,25148,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,25149,0)
 ;;=372.30^^145^1536^14
 ;;^UTILITY(U,$J,358.3,25149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25149,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,25149,1,5,0)
 ;;=5^Conjunctivitis
 ;;^UTILITY(U,$J,358.3,25149,2)
 ;;=^27546
 ;;^UTILITY(U,$J,358.3,25150,0)
 ;;=595.9^^145^1536^15
 ;;^UTILITY(U,$J,358.3,25150,1,0)
 ;;=^358.31IA^5^2
